1 Bronchodilating effects produced by increasing intravenously administered doses of enprofylline and theophylline compared to placebo were evaluated in 20 asthmatic outpatients. 2 Three mean plasma plateaux of enprofylline of 1.5, 2.9 and 4.0 ,ug/ml produced a mean increase in forced expiratory volume in the first second (FEV1.0) as a percentage of baseline, of 12.8%, 18.8% and 30.1%, respectively.3 Comparable plasma plateaux of theophylline i.e. 5.5, 10.8 and 15.2 jig/ml produced a mean increase of FEV1.0 in percent of basal values of 12.4%, 21.6% and 28.2%, respectively. 4 Enprofylline at plasma concentrations above 2.9 ,ug/ml induced more headache and slightly more nausea than theophylline and placebo. Theophylline infusion produced more tremor (finger oscillation) than enprofylline and placebo. 5 Intravenously administered enprofylline produces bronchodilation comparable to theophylline in a mean dose ratio of 3.8.